Triptolide inhibits the proinflammatory potential of myeloid-derived suppressor cells via reducing Arginase-1 in rheumatoid arthritis
Authors:
- 11 December 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 127, 111345
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2020A1515110329)
- National Natural Science Foundation of China (81503317)
- Ministry of Education of the People's Republic of China
- Guangzhou Municipal Science and Technology Project (202201020334)
This publication has 36 references indexed in Scilit:
- Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trialAnnals of the Rheumatic Diseases, 2015
- Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patientsProceedings of the National Academy of Sciences, 2014
- Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2Immunity, 2013
- Myeloid-Derived Suppressor Cells Play Crucial Roles in the Regulation of Mouse Collagen-Induced ArthritisThe Journal of Immunology, 2013
- Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanismsNatural Product Reports, 2012
- Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem CellsScience, 2010
- MicroRNA-155 Regulates Inflammatory Cytokine Production in Tumor-associated Macrophages via Targeting C/EBPβCellular & Molecular Immunology, 2009
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Guidelines for the medical management of osteoarthritisArthritis & Rheumatism, 1995
- Guidelines for the medical management of osteoarthritisArthritis & Rheumatism, 1995